VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 105 filers reported holding VERONA PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,892,000 | -10.1% | 200,000 | 0.0% | 1.95% | -2.6% |
| Q1 2024 | $3,218,000 | -19.1% | 200,000 | 0.0% | 2.00% | -39.2% |
| Q4 2023 | $3,976,000 | +22.0% | 200,000 | 0.0% | 3.29% | -2.7% |
| Q3 2023 | $3,260,000 | -22.9% | 200,000 | 0.0% | 3.38% | -34.0% |
| Q2 2023 | $4,228,000 | +5.3% | 200,000 | 0.0% | 5.12% | -17.2% |
| Q1 2023 | $4,016,000 | +61.1% | 200,000 | +109.7% | 6.19% | +10.0% |
| Q4 2022 | $2,492,567 | – | 95,391 | – | 5.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,369,000 | $47,095,720 | 7.54% |
| NEA Management Company, LLC | 5,108,563 | $111,024,890 | 7.40% |
| Vivo Capital, LLC | 4,249,918 | $84,488,370 | 6.92% |
| Aisling Capital Management LP | 1,115,352 | $22,173,198 | 6.61% |
| Rosalind Advisors, Inc. | 250,000 | $4,970,000 | 4.09% |
| First Turn Management, LLC | 1,206,291 | $23,981,065 | 3.44% |
| Knoll Capital Management, LLC | 200,000 | $3,976,000 | 3.29% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $59,925,258 | 3.20% |
| Tri Locum Partners LP | 293,112 | $5,827,067 | 2.66% |
| Carlyle Group Inc. | 2,457,500 | $48,805,950 | 2.35% |